Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-11 15:46 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Effect of RTB101 on Illness Associated With Respiratory Tract Infections in the Elderly
NCT04139915 · Restorbio Inc. · PHASE3 · withdrawn · last registry update 2019-11-22 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Phase 3 trial RTB-101-204 study did not meet its primary endpoint” | – | Registry record, Restorbio Inc. |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against MTOR within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2020-11-20Also stopped (withdrawn): SWOG Cancer Research Network, Dexamethasone + Docetaxel (NCT04267913)
- 2020-10-28Results posted on the registry: Medinol Ltd., EluNIR Ridaforolimus Eluting Coronary Stent System (NCT03702608)
- 2020-09-24Results posted on the registry: Medinol Ltd., a drug against MTOR (NCT02828917)
- 2020-09-24Results posted on the registry: Medinol Ltd., a drug against MTOR (NCT02834806)
- 2020-09-09Results posted on the registry: Calithera Biosciences, Inc, TAK-228 (NCT03370302)
- 2020-06-09Results posted on the registry: Millennium Pharmaceuticals, Inc., Paclitaxel + Sapanisertib (NCT02725268)
- 2020-05-28Also stopped (terminated): NewLink Genetics Corporation, 1-methyl-D-tryptophan (NCT00739609)
- 2020-04-28Also stopped (withdrawn): Abramson Cancer Center at Penn Medicine, Hydroxychloroquine (HCQ) + Gedatolisib (NCT03400254)
- 2020-04-03Results posted on the registry: Masonic Cancer Center, University of Minnesota, Indoximod + Sipuleucel-T (NCT01560923)
- 2020-04-01Results posted on the registry: Millennium Pharmaceuticals, Inc., MLN0128 (NCT01058707)
- 2020-03-12Results posted on the registry: M.D. Anderson Cancer Center, TAK228 (NCT02727777)
- 2020-03-12Also stopped (terminated): M.D. Anderson Cancer Center, TAK228 (NCT02727777)
- 2020-03-12Also stopped (withdrawn): Gary Schwartz, TAK-228 + Letrozole (NCT02619669)
- 2020-03-03Results posted on the registry: Calithera Biosciences, Inc, Sapanisertib (NCT02197572)
- 2020-03-03Results posted on the registry: National Cancer Institute (NCI), Pazopanib + Pazopanib Hydrochloride (NCT02601209)
- 2020-02-28Results posted on the registry: Millennium Pharmaceuticals, Inc., Sapanisertib + Paclitaxel (NCT02412722)
- 2020-02-25Results posted on the registry: Millennium Pharmaceuticals, Inc., MLN2480 + MLN0128 (NCT02327169)
- 2020-01-27Results posted on the registry: Calithera Biosciences, Inc, Sapanisertib + Fulvestrant (NCT02049957)
- 2019-10-30Results posted on the registry: Millennium Pharmaceuticals, Inc., TAK-228 + TAK-117 (NCT01899053)
- 2019-10-29Results posted on the registry: Memorial Sloan Kettering Cancer Center, MLN0128 (NCT02091531)
- 2019-10-04Also stopped (terminated): University of Florida, Gedatolisib + Paclitaxel (NCT02920450)
- 2019-10-03Results posted on the registry: University of Florida, Gedatolisib + Paclitaxel (NCT02920450)
- 2019-08-08Results posted on the registry: Millennium Pharmaceuticals, Inc., MLN0128 + paclitaxel (NCT01351350)
- 2019-06-11Results posted on the registry: Sanofi, SAR245408 + SAR245409 (NCT01587040)
- 2019-05-20Also stopped (terminated): Samsung Medical Center, AZD2014 (NCT03061708)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision